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Abstract The use of tobacco plants as a novel expression
system for the production of human homotrimeric collagen I is
presented in this report. Constructs were engineered from cDNA
encoding the human proK1(I) chain to generate transgenic
tobacco plants expressing collagen I. The recombinant proK1(I)
chains were expressed as disulfide-bonded trimers and were
shown to fold into a stable homotrimeric triple helix. Moreover,
the recombinant procollagen was subsequently processed to
collagen as it occurs in animals. Large amounts of recombinant
collagen were purified from field grown plant material. The data
suggest that plants are a valuable alternative for the recombinant
production of collagen for various medical and scientific
purposes.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Collagens form a family of extracellular matrix proteins
found in all connective tissues. They represent 30% of total
body proteins in mammalians, the most abundant compo-
nents being the ¢brillar collagens I^III which make up the
cross-striated ¢bril network of extracellular matrices. Collagen
molecules comprise three polypeptides, referred to as K
chains, which assemble to form triple helical domains. The
K chains contain the repeating triple sequence Gly-X-Y in
which X and Y are frequently proline and hydroxyproline
residues, respectively. This sequence is required for the correct
formation of the triple helix since only the glycyl residue can
¢t at the center of the helix and the imino acid residues are
essential for triple helix folding and stabilization [1].
Fibrillar collagen I is the most widely distributed in tissues,
where it occurs with the chain composition [K1(I)]2K2(I).
However, in addition to this form, tissues also contain sub-
stantial amounts of the homotrimer [K1(I)]3. Both molecules
have been shown to form a stable triple helix. The molecule is
synthesized as a procollagen, triple helix formation being ini-
tiated by C-propeptide interactions. Cleavage of the N- and
C-terminal propeptides from the secreted collagen molecule
by specialized enzymes is a prerequisite for ¢bril assembly [2].
Collagen I is primarily a structural protein but it is also
involved in a number of biological events such as early devel-
opment, organogenesis, cell attachment and proliferation, he-
mostasis, wound healing and tissue remodelling. The mechan-
ical properties of this protein, its biological characteristics and
its poor immunogenicity render it suitable for natural-based
biomaterial use [3]. Indeed, collagen I is widely exploited for
medical use, cosmetics, therapeutics and also as gelatin (dena-
tured collagen) in food. However, this material is mainly ex-
tracted from animal tissues, which entails potential viral or
infectious agent contamination risks and allergic reaction
problems. Because the development of an e⁄cient expression
system for such proteins would have numerous applications,
di¡erent cell systems have been developed to produce well-
folded recombinant collagens. Indeed, ¢brillar collagens
have already been expressed in mammalian cells [4^6], insect
cells [7^9] and in yeast [10]. Recently, the production in mouse
milk of a chimeric mini-procollagen molecule has also been
described [11]. The use of plants as an expression system rep-
resents a breakthrough for the production of mammalian pro-
teins. Amongst others, complex functional proteins such as
immunoglobulins [12] and hemoglobin [13] have been success-
fully produced in transgenic plants. Here, we show that to-
bacco plants, transformed by cDNA encoding the human
preproK1 chain of collagen I, are able to produce fully
processed triple helical molecules and thus may represent a
suitable alternative source of collagen for cost-e¡ective large-
scale production.
2. Materials and methods
2.1. Constructions and transformation of tobacco plants
The cDNA clones 1K3 and K22, together encoding the complete
human proK1(I) collagen chain, were obtained by screening a
MG63 (human osteosarcoma cell line, ATCC, 1427) cDNA library
[14] with two Q-32P-labelled oligonucleotides (nucleotides 152^171 and
4268^4274 of the human proK1(I) transcript, numbering from the
translation initiation site). To obtain the three constructs used in
this study, the 1554 bp BamHI-EcoRI fragment from the cDNA clone
K22 was cloned into pBluescriptSK (Stratagene) (clone 1). The EcoRI-
HindIII PCR fragment encoding the carboxy-terminus of the proK1(I)
chain was ligated into the EcoRI and HindIII sites of clone 1 in order
to obtain clone 2. Clone 3 was generated by cloning a 1441 bp XbaI-
BamHI PCR fragment into the plasmid pUC19. This PCR fragment
contains the coding sequence for the amino-telopeptide and the ami-
no-terminus of the central triple helix of the proK1(I) chain. The
DraIII-BamHI fragment was ligated to the DraIII-BamHI sites of
clone 3 to obtain clone 4. Clone 5 was generated by ligating the
XbaI-BamHI fragment of clone 4 to the same sites in clone 2. A
473 bp SacII-NheI PCR fragment encoding the signal peptide and
the N-propeptide of the preproK1(I) chain was ligated to the same
sites in clone 5 and the resultant construct, K1(I), encodes the com-
plete preproK1(I) chain. The NheI PCR-generated restriction site sub-
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stitutes the Asn-158 and Phe-159 to Lys and Leu residues, respectively
(the residues are numbered from the ¢rst methionine). A SacII-NheI
PCR fragment encoding the plant signal peptide of PR-protein
(pathogenesis-related protein), referred to as PRS, [15] was ligated
to the SacII-NheI sites of clone 5 to obtain the PRS(vN-pro) con-
struct. It encodes the signal peptide PRS and the complete proK1(I)
chain except the N-propeptide sequence. For the last construct, a 407
bp NheI-NheI PCR fragment encoding the N-propeptide of the pro-
K1(I) chain was ligated to the NheI site of the construct PRS(vN-pro).
The resultant construct PRSK1(I) encodes the complete proK1(I)
chain in which the natural signal peptide is replaced by PRS. The
di¡erent constructs are illustrated in Fig. 1. All the PCR fragments
have been sequenced.
Constructs were digested by HindIII and ligated to the binary plas-
mid pBIOC21 [16]. This plasmid contains the recombinant coding
region under the control of the enhanced 35S promoter and the 35S
terminator of the cauli£ower mosaic virus. The selectable marker gene
NPT2 is under the control of promoter NOS and the NOS terminator
of Agrobacterium tumefaciens [17]. The resultant constructs were
termed pBIOC-K1(I), pBIOC-PRS(vN-pro) and pBIOC-PRSK1(I), re-
spectively. Transformations were achieved by infecting leaf discs of
tobacco with recombinant A. tumefaciens as previously described [17].
Kanamycin-resistant transformants were selected and regenerated in
order to screen plantlets expressing collagen I.
2.2. Extraction and puri¢cation of collagens
2.2.1. Collagen I standards. Collagens were extracted from fetal
calf bones by pepsin digestion and separated by salt fractionation as
previously described [18]. The 0.7 M NaCl and 0.9 M NaCl precip-
itates were shown to contain the heterotrimeric form [K1(I)]2K2(I) and
the [K1(I)]3 homotrimer, respectively (data not shown).
2.2.2. Recombinant collagen. Plantlets (leaves and stems) were fro-
zen in liquid nitrogen and homogenized in a freezer mill (Spex Indus-
tries, Metuchen, NJ, USA). Total protein was extracted in 50 mM
Tris (pH 7.4), 150 mM NaCl, 2.5 mM EDTA, 1 mM phenylmetha-
nesulfonyl £uoride, 1 mM N-ethylmaleimide at 4‡C overnight and
centrifuged to eliminate insoluble materials. Supernatants were ana-
lyzed by immunoblotting as described below.
Frozen leaves and stems of transformed mature plants were pow-
dered under liquid nitrogen as described above and the homogenate
was extracted in 0.5 M acetic acid containing 0.2 M NaCl for 60 h at
4‡C. After removing insoluble material by centrifugation, the super-
natant containing the recombinant collagen was salt-fractionated at
0.4 M and 0.9 M NaCl. The 0.9 M NaCl precipitate, containing the
recombinant collagen, was dissolved in and dialyzed against 0.1 M
acetic acid and stored at 320‡C until used.
2.3. Western blot analysis
Samples were analyzed by 6% sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE) under reducing or non-reduc-
ing conditions (when indicated) followed by electrotransfer onto poly-
vinylidene di£uoride membranes (Immobilon-P, Millipore) overnight
in 10 mM CAPS (pH 11), 5% methanol. After saturation, membranes
were incubated with polyclonal antibodies against human collagen I
(kindly provided by Dr. D Hartman, Institut Pasteur, Lyon, France)
followed by secondary antibodies conjugated to alkaline phosphatase.
Immunoblots were revealed with the alkaline phosphatase conjugate
substrate kit from Bio-Rad.
2.4. Analytical and electron microscopy methods
To determine N-terminal amino acid sequences, samples were sub-
jected to SDS^PAGE electrophoresis and then electrotransfered. The
bands of interest were excised from the membrane and amino acid
sequencing was performed by automated Edman degradation using an
Applied Biosystems 473A protein sequencer.
For amino acid composition analysis, the 0.9 M NaCl precipitate
containing the recombinant collagen dissolved in 0.1 M acetic acid
was heated at 60‡C for 15 min prior to further puri¢cation by reverse
phase HPLC on a aquapore C8 RP300 column using an aqueous
acetonitrile gradient in the presence of 0.1% tri£uoroacetic acid. The
puri¢ed recombinant K1(I) chains appeared as a single peak and ex-
hibited the expected molecular mass as analyzed by 6% SDS^PAGE
(not shown). The same puri¢cation procedure was carried out on
bovine collagen I homotrimer samples. The amino acid composition,
performed on both samples, was determined after hydrolysis under
vacuum (6 N HCl, 115‡C, 24 h) in presence of 2-mercaptoethanol in a
Pico Tag system (Waters) with a Beckman amino acid analyzer.
For rotary shadowing, samples were diluted to 10 Wg/ml with 0.1 M
acetic acid, mixed with glycerol (1:1), sprayed onto freshly cleaved
mica sheets and immediately placed on the holder of a MED 010
evaporator (Balzers). Rotary shadowing was carried out as previously
described [19]. Observations of replicas were performed with a Philips
CM120 microscope at the ‘Centre de Microscopie Electronique Ap-
plique¤e a' la Biologie et a' la Ge¤ologie, Universite¤ Claude Bernard,
Lyon I’.
2.5. Circular dichroism
Triple helical conformation and thermal stability of the recombi-
nant homotrimer were analyzed by circular dichroism. Spectra were
recorded at 10‡C in 100 mM acetic acid on a CD6 Jobin Yvon spec-
tropolarimeter equipped with a variable temperature unit. Samples of
recombinant collagen and, for comparison, bovine homotrimer were
dissolved in 100 mM acetic acid. Heat denaturation, when necessary,
was performed immediately before the analysis. Measurements were
performed with a 0.1 cm path length cell at a constant rate of 10 nm/
min with a 0.2 nm resolution. Thermal transition curves were meas-
ured on both samples at a concentration of 185 Wg/ml by monitoring
[a] 225 nm as a function of temperature at a heating rate of 10‡C/h.
3. Results and discussion
3.1. Analysis of recombinant collagen I expressed in plantlets
Full-length cDNA encoding the human proK1(I) chain was
used to engineer three di¡erent constructs and to generate
transgenic tobacco plants expressing collagen I (Fig. 1).
Over 20 independent primary transformants were obtained
for each construct. Plantlets were screened for the expression
of recombinant collagen I by Western blotting using polyclon-
al antibodies against human collagen I. Two bands were de-
tected in protein extracts transformed with either pBIOC-
K1(I) (not shown) or pBIOC-PRSK1(I) (Fig. 2A, lane 1).
These two recombinant K1(I)-derived forms migrate at about
160 kDa and 140 kDa, respectively. With the construct lack-
ing the N-propeptide, pBIOC-PRS(vN-pro), two polypeptides
were also detected but the electrophoretic pattern is di¡erent.
The slower band migrated at 140 kDa and the faster one at
Fig. 1. Human proK1(I) constructs. (A) Restriction fragments and
PCR products used for the generation of the proK1(I) expression
constructs are represented below the overlapping cDNA clones 1K3
and K22. (B) depicts the composition of the di¡erent engineered
protein constructs. SP, signal peptide; PRS, plant signal peptide;
NC1, NC2 and NC3, non-collagenous domains; COL1 and COL2,
collagenous domains. Domains are numbered from the carboxy-ter-
minus.
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120 kDa (Fig. 2A, lane 2). The 120 kDa band nearly co-
migrated with the fully processed bovine K1(I) chain and
thus the 160 kDa and 140 kDa bands probably correspond
to intermediate processed forms. N-terminal sequence analysis
of the 140 kDa (Fig. 2A, lane 1) and the 120 kDa (Fig. 2A,
lane 2) bands obtained with the pBIOC-PRSK1(I) and
pBIOC-PRS(vN-pro) constructs, respectively, indicated that
they both start with the ¢rst amino acid after the plant signal
peptide sequence (Fig. 2B) and thus show that these two
bands were not processed at their N-terminal extensions.
Under non-reducing conditions, only the upper bands ob-
tained with each construct migrated as high molecular mass
products corresponding to trimers (Fig. 2C). These results
indicated that whatever the construct was, the recombinant
collagen was synthesized in plantlets as a precursor which
was disul¢de-linked through its C-propeptides. This precursor
underwent C-terminal processing that removed the C-propep-
tides but retained, when present in the construct, the complete
N-propeptide.
3.2. Puri¢cation of recombinant collagen I from mature
transgenic plants
The amount of expressed collagen I was shown to vary
from one plant to another. Therefore, only selected plants
(transformed with pBIOC-PRS(vN-pro) or pBIOC-PRSK1(I))
for which the collagen expression level was estimated to be
more than 10 mg/100 g of powdered plants were grown to
maturity for carrying out puri¢cation of high quantities of
recombinant protein. The recombinant collagen was thus ex-
tracted and puri¢ed from ¢eld grown plants mature plant
extracts on the basis of the known physical and chemical
properties of collagens. Collagen is acid soluble while acid-
i¢cation causes most of the plant proteins to precipitate. Rais-
ing the salt concentration allowed further separation of re-
combinant collagen from the remaining proteins as judged
by 5^15% SDS^PAGE (Fig. 3A). Purity of recombinant col-
lagen I in the 0.9 M NaCl precipitate is estimated to be about
90% based on the percentage of glycine and proline residues
obtained with amino acid composition analysis. Approxi-
Fig. 2. A: Western blot of recombinant K1(I) collagen in crude ex-
tracts from tobacco plantlets. Lane 1: transgenic pBIOC-PRSK1(I).
Lane 2: transgenic pBIOC-PRS(vN-pro). Lane 3: wild-type plant.
Lane 4: puri¢ed bovine [K1(I)]2K2(I) collagen I. B: N-terminal pep-
tide sequences of recombinant proK1(I) chain-derived forms ob-
tained from pBIOC-PRSK1(I) and pBIOC-PRS(vN-pro) transgenic
tobacco protein extracts. Residues derived from N-terminal sequenc-
ing are aligned with the sequence deduced from the cDNA of each
construct. The modi¢cations made for engineering the constructs
are bold face type and the signal peptide sequence is underlined. Ar-
rowheads indicate the PRS cleavage site determined by N-terminal
sequencing. C: Formation of inter-chain disul¢de bonds analyzed
by Western blotting of the recombinant proK1(I)-derived forms
under reducing (lanes 1 and 3) and non-reducing conditions (lanes 2
and 4). Asterisks indicate the running positions of trimers. Molecu-
lar masses (in kDa) are indicated for recombinant protein forms on
the left of A and C.
Fig. 3. A: Puri¢cation of recombinant collagen by salt fractionation
of acid soluble crude extracts from pBIOC-PRS(vN-pro) (lanes 2^4)
and pBIOC-PRSK1(I) (lane 5) mature transgenic plants. Samples
were analyzed by 5^15% SDS^PAGE under reducing conditions and
stained with Coomassie blue. Lane 1: puri¢ed bovine heterotrimeric
collagen I. Lane 2: electrophoretic pattern of acid soluble crude
transgenic tobacco extract. Lane 3: 0.4 M NaCl supernatant frac-
tion. Lanes 4 and 5: 0.9 M NaCl precipitate containing puri¢ed re-
combinant collagen I (rColl I) from pBIOC-PRS(vN-pro) (lane 4)
and from pBIOC-PRSK1(I) (lane 5). Left, running positions of pro-
tein standards are indicated in kDa. B: Comparison of the human
K1(I) chain N-propeptide cleavage site (arrow) [17] with the N-pro-
peptide cleavage site (arrowhead) of rColl I, puri¢ed from pBIOC-
PRSK1(I) mature plants, determined by N-terminal amino acid se-
quencing (bottom line). Residue substitutions are bold face type; X,
unidenti¢ed residue.
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mately 3 g of puri¢ed recombinant collagen is thus obtained
per 100 kg of powdered plants allowing its molecular charac-
terization.
As judged by the electrophoretic pattern, the major band
detected in pBIOC-PRS(vN-pro) mature plant extracts nearly
co-migrated with the pepsinized bovine K1(I) corresponding
to the C-propeptide processed form (Fig. 3A, lanes 2^4). Two
bands migrating at 140 kDa and 120 kDa, respectively, were
detected in pBIOC-PRSK1(I) mature plant extracts, whereas
the 160 kDa form, present in plantlet extracts, was not found.
The intensity of the 140 kDa band, which corresponds in size
to the C-terminal processed form, decreased during puri¢ca-
tion steps resulting in the increase of the 120 kDa band in-
tensity. With time, the 120 kDa band became the major band
detected in the puri¢ed sample (Fig. 3A, lane 5). This sug-
gested that the recombinant product underwent further N-
terminal proteolytic trimming during puri¢cation steps. In-
deed, N-terminal sequencing indicated that a large part of
the N-propeptide was removed. We determined the start at
Ser-259 (Fig. 3B), two residues downstream of the natural
cleavage site of N-proteinase which occurred at the Pro-
256^Gln-259 bond [20]. Thus, as it occurs for the heterotri-
meric collagen I extracted from tissues, the fully processed
form retains about 20 amino acid residues at the N-terminal
extremity referred to as the N-telopeptide (see Fig. 1). Con-
sequently, whatever the construct used for plant transforma-
tion, spanning or not the complete N-propeptide, the ¢nal
recombinant product is fully processed to collagen. This prod-
uct is referred hereafter to as rColl I (Fig. 3A).
3.3. Molecular characterization of the recombinant collagen
Prolyl-hydroxylation of target residues within the collage-
nous domain is known to be critical for the formation and
stability of the helix. Although plants do contain a prolyl 4-
hydroxylase, its substrate speci¢city, even though not abso-
lute, is characterized by the tetra (L-prolyl) sequence [21]. The
plant enzyme cannot ensure the prolyl-hydroxylation of the
collagenous triplet Xaa-Pro-Gly. Indeed, amino acid analysis
showed that the proline residues of rColl I are not hydroxy-
lated (Table 1), which correlates with the slightly faster migra-
tion of the recombinant K1(I) chains compared to the stand-
ard K1(I) chain migration (Fig. 3A). Hydroxylation was
shown to be required for triple helix nucleation and propaga-
tion of the ¢brillar collagen III [22]. Nevertheless, the spec-
trum obtained by circular dichroism for the recombinant pro-
tein (Fig. 4A) is typical of a triple helical conformation. In
addition, we showed that puri¢ed rColl I is resistant to trypsin
at room temperature, indicating that the recombinant homo-
trimeric K1(I) chains do form stable triple helices (Fig. 4C).
The well-folded triple helical structure was also con¢rmed by
rotary shadowing experiments which revealed the presence of
the characteristic 300 nm long rod-like molecules in puri¢ed
rColl I samples (Fig. 4D). These molecules present the same
features in terms of length and shape as native collagen I
molecules. Altogether, these data attest to the structural con-
formity of the collagen produced by the transformed tobacco
with native collagen and show that, even though unhydroxy-
lated, collagen chains can assemble into stable correctly folded
triple helices in plant systems.
It has previously been reported that the thermal stability of
collagens is directly related to the hydroxyproline content.
The inhibition of hydroxylation by incubating cultured ¢bro-
blasts with K,KP-bipyridyl, an inhibitor of prolyl hydroxylase,
resulted in the production of unhydroxylated collagen with a
melting temperature of 24‡C [23,24]. As a consequence of the
Table 1
Amino acid composition of recombinant collagen I
Amino acid rColl I residues/
100 residues
Bovine coll I homotrimer
residues/100 residues
Hyp 0.53 9.04
Pro 18.75 10.32
Asp 4.87 4.66
Thr 1.67 1.91
Ser 4.74 3.79
Glu 8.87 10.13
Gly 33.85 33.53
Ala 10.49 9.74
Cys ND ND
Val 2.12 1.74
Met 0.56 0.70
Ile 0.69 0.80
Leu 2.28 2.65
Tyr 0.32 0.29
Phe 1.03 1.15
His 0.58 0.57
Hyl 0.08 1.63
Lys 4.13 2.46
Trp ND ND
Arg 4.66 4.96
ND, not determined.
Fig. 4. Triple helix formation and thermal stability of puri¢ed rColl
I molecules. A: Circular dichroism spectra of rColl I were recorded
at 10‡C (a) and at 53‡C after denaturation (b). B: Thermal transi-
tion curve of rColl I as measured by circular dichroism at 225 nm.
C: Formation of trypsin-resistant homotrimers. Puri¢ed rColl I was
treated with (lane 2) or without (lane 1) trypsin at 25‡C for 10 min
at an enzyme/substrate ratio of 1:10. Positive control was achieved
with heat-denatured (60‡C for 20 min) rColl I samples (lane 3).
Samples were analyzed by 6% SDS^PAGE under reducing condi-
tions and stained with Coomassie blue. Right, molecular masses of
protein standards are indicated in kDa. D: Rotary shadowed elec-
tron micrographs of puri¢ed recombinant homotrimers (rColl I).
Representative ¢eld of recombinant molecules (top panel) and a se-
lected (box) enlarged molecule (bottom panel) showing the charac-
teristic 300 nm long rod-like collagen I molecule.
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lack of prolyl-hydroxylation of the collagenous substrate in
plant, it was thus expected that the thermal stability of our
recombinant molecules would decrease compared to fully hy-
droxylated collagen. Indeed, the transition curves we obtained
indicate that the recombinant collagen melts at 30.5‡C (Fig.
4B) instead of 41.5‡C for the homotrimer puri¢ed from bo-
vine tissues (data not shown).
Interestingly, our results demonstrate that plants which a
priori do not contain the speci¢c post-translational equipment
necessary for collagen molecule assembly guarantee the pro-
duction of triple helical molecules. We have also showed that
inter-chain disul¢de bonds between the C-propeptides are
formed as in animals. The folding and assembly of procolla-
gen is a complex process and evidence is accumulating that
suggests the involvement in chain selection and correct assem-
bly of a collagen-speci¢c molecular chaperone. The mamma-
lian protein disul¢de isomerase (PDI) was shown to bind to
the C-propeptide prior to trimer assembly thereby also acting
as a molecular chaperone during chain assembly [25]. Since
PDI is present in tobacco plant cells [26], it might be involved
in recombinant collagenous chain assembly.
Lastly, our data also show that plants provide a good sys-
tem for producing fully processed molecules, which is a pre-
requisite for ¢bril formation. Spontaneous processing of pro-
collagen to mature collagen has been shown to occur
e⁄ciently in tobacco plant extracts. This avoids the use of
pepsin to cleave N- and C-terminal extensions which generally
persist in recombinant collagen molecules obtained from other
expression systems [4,5,7^10] including transgenic animals
[11]. Moreover, electrophoretic patterns and N-terminal se-
quence analysis suggest that endogenous proteases cleaved
at single sites within the N- and C-propeptides. N-propeptide
cleavage occurs immediately downstream of the normal cleav-
age site of the N-proteinase. This result suggests that N- and
C-propeptide cleavage can be ensured by enzymes other than
the animal-speci¢c enzymes, namely N-proteinase [20] and
BMP-1 (C-proteinase) [27], presumably because the cleavage
of both N- and C-propeptides occurs within the less folded
regions that link two well-de¢ned domains. Such regions
might be more sensitive to proteases.
In conclusion, the data reported here demonstrate that col-
lagen, a protein involved in a number of biomaterial and
biotechnological applications, can be produced as fully pro-
cessed triple helical molecules by transgenic tobacco plants.
Although several other expression systems have been success-
fully developed for producing procollagens, the advantages of
using plants include a high level expression of recombinant
protein, a large-scale and cost-e¡ective production as well as
the avoidance of health risks in terms of viruses and infectious
agents potentially present in other systems. The use of plants
as bioreactors for collagen production makes it possible to
produce unlimited quantities of other human collagens. The
ease of co-expression in such a system also enables the pro-
duction of heterotrimeric collagens as well as fully hydroxy-
lated collagens by co-transformation in plants of cDNA en-
coding animal prolyl 4-hydroxylase.
In addition, our results have important implications for the
development of genetically modi¢ed plants as sources of ani-
mal proteins. Indeed, the use of the tobacco plant for animal
protein production potentially opens new possibilities for the
exploitation of the already existing knowledge of the cultiva-
tion and processing of this plant in the tobacco industry.
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